Ossur hf (OSSR)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Ossur hf (OSSR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011676
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイスランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ossur hf. (Ossur) is an orthopedic devices company. It develops, manufactures and sells prosthetics, and bracing and support products. The company’s key areas of expertise include silicone, carbon composites, mechatronics and textiles. Ossur offers ankle and foot supports, knee braces, neck and spine support products and walkers; compression socks, thighs and bandages; and a full range of premium lower limb prosthetics, including liners, knees and feet; and others. It operates manufacturing facilities in Americas, Europe, the Middle East and Africa and Asia-Pacific. The company distributes its products through its subsidiaries and also through a network of distributors across the Americas, Europe, the Middle East, Africa and Asia-Pacific. Ossur is headquartered in Reykjavik, Iceland.

Ossur hf (OSSR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ossur hf, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Ossur hf, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Ossur hf, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Ossur hf, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Ossur hf, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Ossur hf, Medical Equipment, Deal Details 10
Partnerships 10
Ossur Enters into Licensing Agreement with SpringActive 10
Ossur Enters into Distribution Agreement with ArjoHuntleigh 11
Acquisition 12
Ossur Acquires Medi Prosthetics from medi 12
Ossur Acquires Touch Bionics for USD39 Million 13
Ossur Completes Acquisition Of TeamOlmed For US$46.4 Million 14
Ossur hf – Key Competitors 15
Ossur hf – Key Employees 16
Ossur hf – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 19
Financial Announcements 19
Oct 24, 2017: Ossur Hf: Q3 Results 2017 19
Jul 25, 2017: Ossur hf: Q2 Results 2017 20
Apr 27, 2017: Ossur Q1 Results 2017 22
Feb 07, 2017: Ossur Hf: Q4 and FY Results 2016 27
Oct 26, 2016: Ossur Hf: Q3 Results 2016 28
Jul 21, 2016: Ossur: Q2 Results 2016 29
Apr 27, 2016: Ossur hf: Q1 Results 2016 30
Feb 02, 2016: Ossur Hf: Q4&FY Results 2015 31
Corporate Communications 33
Nov 09, 2017: Ossur Hf: Management Changes 33
Other Significant Developments 34
Feb 08, 2017: NIB funds prosthetic and orthotic R&D in Iceland 34
Jan 25, 2016: Global Prosthetics Leaders Ossur and Ottobock Partner on Historic Research Trust Fund at the University of Iceland 35
Jan 15, 2016: Ossur Receives EPSRC Grant 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Ossur hf, Medical Equipment, Key Facts, 2016 2
Ossur hf, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Ossur hf, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Ossur hf, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Ossur hf, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Ossur hf, Deals By Market, 2011 to YTD 2017 8
Ossur hf, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Ossur Enters into Licensing Agreement with SpringActive 10
Ossur Enters into Distribution Agreement with ArjoHuntleigh 11
Ossur Acquires Medi Prosthetics from medi 12
Ossur Acquires Touch Bionics for USD39 Million 13
Ossur Completes Acquisition Of TeamOlmed For US$46.4 Million 14
Ossur hf, Key Competitors 15
Ossur hf, Key Employees 16
Ossur hf, Subsidiaries 17

★海外企業調査レポート[Ossur hf (OSSR)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Weifa AS-製薬・医療分野:企業M&A・提携分析
    Summary Weifa AS (Weifa), a subsidiary of Weifa ASA, is a healthcare solution provider that research, develops, produces, distributes and sells medicines, and lifestyle products. The company’s products comprise Tylenol, paracetduo, ibux, ibux gel, tiger balm, proxan, nazareth, dexyl, tussin, bronkyl …
  • ShaMaran Petroleum Corp. (SNM):企業の財務及び戦略的SWOT分析
    Summary ShaMaran Petroleum Corp. (ShaMaran), formerly Bayou Bend Petroleum Ltd. is an oil and gas company that explores and produces oil and gas assets. The company owns direct interest in Atrush petroleum property located in Kurdistan in Northern Iraq. It operates pre-production stage of its apprai …
  • Sinclair Broadcast Group, Inc. (SBGI):企業概要、財務及び戦略的SWOT分析
    Summary Sinclair Broadcast Group, Inc. (SBG) is a television broadcasting service provider. The company offers ownership or provision of programming, operating and sales services to television stations. Its television group includes FOX, ABC, MyTV, CW, CBS, NBC, Univision and Azteca affiliates. SBG …
  • Levi Strauss & Co.:企業の戦略・SWOT・財務分析
    Levi Strauss & Co. - Strategy, SWOT and Corporate Finance Report Summary Levi Strauss & Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Astronics Corporation:戦略・SWOT・企業財務分析
    Astronics Corporation - Strategy, SWOT and Corporate Finance Report Summary Astronics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Merrimack Pharmaceuticals, Inc. (MACK):企業の財務及び戦略的SWOT分析
    Summary Merrimack Pharmaceuticals, Inc. (Merrimack) is a biopharmaceutical company that discovers, develops and provides therapies for the treatment of autoimmune disease and cancer. The company’s products include MM-121, MM-111, MM-151, MM-398, MM-141, MM-301 and MM-302. It currently has six oncolo …
  • Galaxy Entertainment Group Limited :企業の戦略・SWOT・財務分析
    SummaryGalaxy Entertainment Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the c …
  • Jumbo Interactive Ltd (JIN):企業財務及び戦略的SWOT分析
    Summary Jumbo Interactive Ltd (Jumbo) is a retailer of lottery tickets that offers digital marketing solutions. The company products comprise digital instants, smart signs, internet sales platform, digital marketing, websites, fun pickers and others. It also provides online distribution channels to …
  • Gen-Probe Incorporated:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Gen-Probe Incorporated Mergers …
  • Van Genechten Packaging N.V.:企業の戦略・SWOT・財務分析
    SummaryVan Genechten Packaging N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company …
  • Adamjee Insurance Company Limited:企業の戦略・SWOT・財務分析
    SummaryAdamjee Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the co …
  • Oxford Pharmascience Group Plc (OXP):企業財務及び戦略的SWOT分析
    Summary Oxford Pharmascience Group Plc (Oxford Pharmascience) is a drug development company that develops improved formulations of non-steroidal anti-inflammatory drugs and statins. The company’s products include reduced gastric irritation taste masked ibuprofen, reduced gastric irritation taste mas …
  • Opexa Therapeutics Inc (OPXA):企業財務及び戦略的SWOT分析
    Summary Opexa Therapeutics Inc (Opexa), formerly PharmaFrontiers Corp. is a biopharmaceutical company that focuses on the development of personalized immunotherapies for autoimmune disorders, rheumatoid arthritis, diabetes and heart failure. The company’s portfolio of products comprise Tcelna, a T-c …
  • National Jewish Health:企業のM&A・提携動向(医療分野)
    Summary National Jewish Health (NJH), formerly National Jewish Medical and Research Center is a respiratory hospital that offers research and treatment of pulmonary, cardiac, immune and related disorders. The hospital provides services in the areas of allergy, asthma, cardiology, clinical immunology …
  • VGX Pharmaceuticals, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' VGX Pharmaceuticals, Inc. Merge …
  • Reliance Capital Limited:企業の戦略・SWOT・財務分析
    SummaryReliance Capital Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • lululemon athletica inc.:企業の戦略・SWOT・財務分析
    Summarylululemon athletica inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • Quidel Corp (QDEL):企業のM&A・提携動向(医療機器分野)
    Summary Quidel Corp (Quidel) develops, manufactures and markets rapid diagnostic testing solutions that find applications in infectious diseases, gastrointestinal diseases and women’s health. The company offers cell line products; diagnostic immunoassays including visually read rapid lateral flow te …
  • Valensa International, LLC (Formerly U.S. Nutraceuticals, LLC):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Valensa International, LLC (For …
  • Voltamp Energy SAOG (VOES):企業の財務及び戦略的SWOT分析
    Summary Voltamp Energy SAOG (SAOG) is an electric equipment company that manufactures and markets transformers and switchgear. The company’s products include power transformers, distribution transformers, LV switchgear and MV switchgear. It offers transformer of different types such as oil filled di …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆